Immunogenicity 15884
Sample ID
3903
Response
Positive
Tumor Type
Melanoma
Gene Symbol
KIF1BP
Transcript ID
None
HLA INFO
B*38:01
TCR INFO
CDR3ACAVHRDYKLSF
TRBVBV-14
TRAVAV1-1
CDR3BCASSPGPNQPQHF
Full length protein sequence (621 aa)
MANVP
1
WAEVC
6
EKFQA
11
ALALS
16
RVELH
21
KNPEK
26
EPYKS
31
KYSAR
36
ALLEE
41
VKALL
46
GPAPE
51
DEDER
56
PEAED
61
GPGAG
66
DHALG
71
LPAEV
76
VEPEG
81
PVAQR
86
AVRLA
91
VIEFH
96
LGVNH
101
IDTEE
106
LSAGE
111
EHLVK
116
CLRLL
121
RRYRL
126
SHDCI
131
SLCIQ
136
AQNNL
141
GILWS
146
EREEI
151
ETAQA
156
YLESS
161
EALYN
166
QYMKE
171
VGSPP
176
LDPTE
181
RFLPE
186
EEKLT
191
EQERS
196
KRFEK
201
VYTHN
206
LYYLA
211
QVYQH
216
LEMFE
221
KAAHY
226
CHSTL
231
KRQLE
236
HNAYH
241
PIEWA
246
INAAT
251
LSQFY
256
INKLC
261
FMEAR
266
HCLSA
271
ANVIF
276
GQTGK
281
ISATE
286
DTPEA
291
EGEVP
296
ELYHQ
301
RKGEI
306
ARCWI
311
KYCLT
316
LMQNA
321
QLSMQ
326
DNIGE
331
LDLDK
336
QSELR
341
ALRKK
346
ELDEE
351
ESIRK
356
KAVQF
361
GTGEL
366
CDAIS
371
AVEEK
376
VSYLR
381
PLDFE
386
EAREL
391
FLLGQ
396
HYVFE
401
AKEFF
406
QIDGY
411
VTDHI
416
EVVQD
421
HSALF
426
KVLAF
431
FETDM
436
ERRCK
441
MHKRR
446
IAMLE
451
PLTVD
456
LNPQY
461
YLLVN
466
RQIQF
471
EIAHA
476
YYDMM
481
DLKVA
486
IADRL
491
RDPDS
496
HIVKK
501
INNLN
506
KSALK
511
YYQLF
516
LDSLR
521
DPNKV
526
FPEHI
531
GEDVL
536
RPAML
541
AKFRV
546
ARLYG
551
KIITA
556
DPKKE
561
LENLA
566
TSLEH
571
YKFIV
576
DYCEK
581
HPEAA
586
QEIEV
591
ELELS
596
KEMVS
601
LLPTK
606
MERFR
611
TKMAL
616
T
621
Mutation Information
DNA mutation:
None
Peptide Range:
244 ~ 251
Mut AA position:
246 (3 in Wild Type peptide)
Alignment
Wild Type:
"YHPIEWAI
||.|||||
Mutant:
YHSIEWAI"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) KIAA1279
Checkpoint
Blockade
None
ACT
N
Vaccination
N
Curative
Effect
None
minimal_peptide
Y
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
DCs
Assay
ELISPOT